The Department of DEPARTMENT holds DEPARTMENT 696 seminars on DATE / TIME / LOCATION during the semester. Speakers with no university following their name are DEPT 696 students presenting a seminar to fulfill a graduate program requirement.

Other seminar series: Industrial and Molecular Pharmaceutics | Medicinal Chemistry & Molecular Pharmacology | Pharmacy Practice

Speaker / Title Date/Time Location
Dr. Elisa Tomat - Engineering Intracellular Iron Sequestration to Target Cancer Growth RHPH 164
Dr. Yuliya Nefedova - Targeting Myeloid Cells to Control Tumor Progression RHPH 164
Dr. Jonah Vilseck - Investigating Molecular Recognition and Accelerating Free Energy Calculations with Lambda Dynamics RHPH 164
Dr. Jessi Blackburn - Zebrafish models uncover targetable mechanisms of self-renewal in Acute Lymphoblastic Leukemia RHPH 164
Dr. Zhiping Pang - Synaptic Regulation in Health and Disease LWSN 1142
Dr. Evan Cornett - Lysine Methylation Signaling: Detection, Quantification, and Substrate Discovery RHPH 164
No Seminar - Spring Break - No Seminar - Spring Break RHPH 164
Dr. Bruce Armitage - PNA: Bridging the Protein and Nucleic Acid Worlds RHPH 164
Dr. Libin Ye - Conformational Dynamics and Function of an Intermediate GPCR-Gαβγ Complex RHPH 164
No Seminar- Final Exams Week - No Seminar- Final Exams Week RHPH 164
Dr. Joshua Rosenthal - Rewriting the Cephalopod Neural Transcriptome by mRNA Editing RHPH 164
Dr. Tatyana Igumenova - Regulation of Lipid Signaling by Peripheral Membrane Proteins RHPH 164
No Seminar- Thanksgiving Break - No Seminar- Thanksgiving Break RHPH 164
Dr. William Pomerantz - Chemical Epigenetics Approaches for Developing Selective Inhibitors and Degraders of Bromodomain-Containing Proteins RHPH 164
Dr. Jennifer Golden - Expanding Quinazolinone-Based Chemistry: A Gateway to Anti-Alphavirus and Antiparasitic Agent Discovery and Development RHPH 164
Dr. Webster Santos - Academic Drug Discovery: Putting Exercise in a Pill & Drugging the Sphingosine-1-Phosphate Pathway RHPH 164
TBD - TBD RHPH 164
Dr. Sandro Matosevic - Reprogramming Natural Killer Cells for Immunotherapy of Cancer RHPH 164
Dr. Dan Ysselstein - Transition from Academia to Biotech; Bringing Glucocerebrosidase Activators to the Clinic RHPH 164
TBD - TBD RHPH 164
Dr. Channabasavaiah Gurumurthy - Technological Advances in CRISPR Genome Editing and Gene Therapy RHPH 164
Dr. Richard Silverman, The Mark Cushman Distinguished Lectureship in Medicinal Chemistry - Inhibition of Protein Aggregation and the Development of NU-9 for Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases RHPH 164
Dr. Erin Eun-Young Ahn - A Story of RNA Splicing, Transcription, and SON-Shine: How Cancer Research Illuminated a Neurodevelopment Disorder RHPH 164
Dr. Pablo Perez-Pinera - Therapeutic Applications of Base Editing RHPH 164
Dr. Jaeyeon Kim - Pharmacologic Prevention of Ovarian and Breast Cancer in BRCA1 Carriers RHPH 164